Drug that delays onset of type 1 diabetes gets approval in US
In an ongoing trial, the drug teplizumab delayed the onset of type 1 diabetes in children and adults by nearly three years, compared with a placebo
Landwebs
0
0
In an ongoing trial, the drug teplizumab delayed the onset of type 1 diabetes in children and adults by nearly three years, compared with a placebo
/cdn.vox-cdn.com/uploads/chorus_asset/file/24430706/elon_musk_twitter_for_you.png)
